Search results for "Heart failure"


 
Results 81 - 90 of about 462 for "Heart failure".
Sort by: Relevance | Newest | Oldest

Effects of heart failure therapies on quality of life compared

Sacubitril/valsartan may improve limitations in physical and social activities that are important to patients with heart failure, researchers noted.
https://immattersacp.org/weekly/archives/2018/04/10/1.htm
10 Apr 2018

Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes

Type 2 diabetes was associated with greater risk for all-cause mortality in patients with ischemic and nonischemic heart failure, previous revascularization was associated with better survival, and most patients with type 2 diabetes and nonischemic heart failure had at least 1 treatable comorbid condition associated with heart failure risk.
https://immattersacp.org/weekly/archives/2016/09/20/4.htm
20 Sep 2016

A living guideline for depression treatment

ACP recommends choosing between a second-generation antidepressant or cognitive behavioral therapy for adults in the acute phase of moderate to severe major depressive disorder.
https://immattersacp.org/archives/2023/06/a-living-guideline-for-depression-treatment.htm
1 Jun 2023

Sacubitril-valsartan appears cost-effective in certain heart failure patients

Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016

CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care

A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://immattersacp.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016

Cardiac rehab uptake remains low, despite benefits

Estimates from the American Heart Association suggest that only about 20% to 30% of eligible patients ever receive the intervention.
https://immattersacp.org/archives/2022/03/cardiac-rehab-uptake-remains-low-despite-benefits.htm
1 Mar 2022

AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products

The scientific statement identifies prescription medications that may exacerbate underlying myocardial dysfunction, prescription drugs known to cause direct myocardial toxicity, and the sodium level of some over-the-counter medications, among other concerns.
https://immattersacp.org/weekly/archives/2016/07/19/5.htm
19 Jul 2016

CBT for comorbid heart failure and depression may only work for the latter

The authors described the reduced anxiety and fatigue, improved social functioning, and better health-related quality of life as especially encouraging results in light of the negative findings of other trials.
https://immattersacp.org/weekly/archives/2015/10/06/6.htm
6 Oct 2015

Factoring drug costs into diabetes decisions

A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://immattersacp.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022

Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial

Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next